Companies researching Induced pluripotent stem cells (ipscs)
Induced pluripotent stem cells (iPSCs) are lab‑generated stem cells created by reprogramming adult skin or blood cells to an embryonic‑like state, providing an unlimited source of human cells for therapeutic and regenerative medicine research.
1,697
companies
List of companies that research Induced pluripotent stem cells (ipscs)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Security and Investigations | 1k | $7.2M | Induced pluripotent stem cells (ipscs) | |
United States | Oil and Gas | 250 | $70M | Induced pluripotent stem cells (ipscs) | |
United States | Oil and Gas | 3.4k | Induced pluripotent stem cells (ipscs) | ||
United States | Biotechnology Research | 21k | $26B | Induced pluripotent stem cells (ipscs) | |
Luxembourg | Biotechnology Research | 61k | $6.9B | Induced pluripotent stem cells (ipscs) | |
France | Research Services | 550 | Induced pluripotent stem cells (ipscs) | ||
United Kingdom | Higher Education | 22k | $171M | Induced pluripotent stem cells (ipscs) | |
France | Pharmaceutical Manufacturing | 92k | $46B | Induced pluripotent stem cells (ipscs) | |
Japan | Pharmaceutical Manufacturing | 12k | Induced pluripotent stem cells (ipscs) | ||
United Kingdom | Pharmaceutical Manufacturing | 98k | $35B | Induced pluripotent stem cells (ipscs) |
Showing top companies out of 1,697 that research Induced pluripotent stem cells (ipscs). Get the full list on TheirStack.
Frequently asked questions









